These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 28012934)
1. Costs associated with treatment of severe combined immunodeficiency-rationale for newborn screening in Sweden. Gardulf A; Winiarski J; Thorin M; Heibert Arnlind M; von Döbeln U; Hammarström L J Allergy Clin Immunol; 2017 May; 139(5):1713-1716.e6. PubMed ID: 28012934 [No Abstract] [Full Text] [Related]
2. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data. Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725 [TBL] [Abstract][Full Text] [Related]
3. Fiscal implications of newborn screening in the diagnosis of severe combined immunodeficiency. Kubiak C; Jyonouchi S; Kuo C; Garcia-Lloret M; Dorsey MJ; Sleasman J; Zbrozek AS; Perez EE J Allergy Clin Immunol Pract; 2014; 2(6):697-702. PubMed ID: 25439359 [TBL] [Abstract][Full Text] [Related]
4. Population-based newborn screening for severe combined immunodeficiency. Puck JM Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):78-80. PubMed ID: 19418625 [No Abstract] [Full Text] [Related]
5. Systematic evidence review of newborn screening and treatment of severe combined immunodeficiency. Lipstein EA; Vorono S; Browning MF; Green NS; Kemper AR; Knapp AA; Prosser LA; Perrin JM Pediatrics; 2010 May; 125(5):e1226-35. PubMed ID: 20403930 [TBL] [Abstract][Full Text] [Related]
6. Societal value of newborn screening for severe combined immune deficiency in Arkansas: An economic analysis. Hays LH Public Health Nurs; 2019 Jul; 36(4):541-544. PubMed ID: 30945355 [TBL] [Abstract][Full Text] [Related]
7. [Neonatal screening for severe combined immunodeficiency: the DEPISTREC study]. Thomas C; Mirallié S; Audrain M; Dert C; Arch Pediatr; 2015 May; 22(5 Suppl 1):73-4. PubMed ID: 26112529 [No Abstract] [Full Text] [Related]
8. Cost-effectiveness of newborn screening for severe combined immunodeficiency. Van der Ploeg CPB; Blom M; Bredius RGM; van der Burg M; Schielen PCJI; Verkerk PH; Van den Akker-van Marle ME Eur J Pediatr; 2019 May; 178(5):721-729. PubMed ID: 30805731 [TBL] [Abstract][Full Text] [Related]
9. A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening. Al Sukaiti N; Ahmed K; Alshekaili J; Al Kindi M; Cook MC; Farsi TA Front Immunol; 2020; 11():623199. PubMed ID: 33519828 [TBL] [Abstract][Full Text] [Related]
11. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening. de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ; Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249 [TBL] [Abstract][Full Text] [Related]
12. Neonatal screening for severe combined immune deficiency. Puck JM Curr Opin Allergy Clin Immunol; 2007 Dec; 7(6):522-7. PubMed ID: 17989529 [TBL] [Abstract][Full Text] [Related]
13. Newborn Screening for Severe Combined Immunodeficiency in the United States: Lessons Learned. Dorsey MJ; Puck JM Immunol Allergy Clin North Am; 2019 Feb; 39(1):1-11. PubMed ID: 30466767 [TBL] [Abstract][Full Text] [Related]
14. Expert commentary: practical issues in newborn screening for severe combined immune deficiency (SCID). Puck JM; Routes J; Filipovich AH; Sullivan K J Clin Immunol; 2012 Feb; 32(1):36-8. PubMed ID: 22012274 [No Abstract] [Full Text] [Related]
15. The Wisconsin approach to newborn screening for severe combined immunodeficiency. Verbsky J; Thakar M; Routes J J Allergy Clin Immunol; 2012 Mar; 129(3):622-7. PubMed ID: 22244594 [TBL] [Abstract][Full Text] [Related]
16. Screening for and treatments of congenital immunodeficiency diseases. Verbsky J; Routes J Clin Perinatol; 2014 Dec; 41(4):1001-15. PubMed ID: 25459787 [TBL] [Abstract][Full Text] [Related]
17. Neonatal screening for severe combined immunodeficiency caused by an adenosine deaminase defect: a reliable and inexpensive method using tandem mass spectrometry. Azzari C; la Marca G; Resti M J Allergy Clin Immunol; 2011 Jun; 127(6):1394-9. PubMed ID: 21624616 [TBL] [Abstract][Full Text] [Related]
18. State, federal efforts under way to identify children with "bubble boy syndrome". Kuehn BM JAMA; 2010 Oct; 304(16):1771-3. PubMed ID: 20978250 [No Abstract] [Full Text] [Related]
19. Cost-Effectiveness/Cost-Benefit Analysis of Newborn Screening for Severe Combined Immune Deficiency in Washington State. Ding Y; Thompson JD; Kobrynski L; Ojodu J; Zarbalian G; Grosse SD J Pediatr; 2016 May; 172():127-35. PubMed ID: 26876279 [TBL] [Abstract][Full Text] [Related]
20. Abnormal T-Cell Receptor Excision Circle Newborn Screen: What Next? Prince BT; Routes JM J Allergy Clin Immunol Pract; 2018; 6(1):318-319. PubMed ID: 29310763 [No Abstract] [Full Text] [Related] [Next] [New Search]